Search Query :
5UVC
Design, synthesis, and evaluation of the first selective and potent g-protein-coupled receptor kinase 2 (grk2) inhibitor for the potential treatment of heart failure Deposition Author(s): Hoffman, I.D. , Lawson, J.D.
Date: 2017-02-20 Method: X-RAY DIFFRACTION Resolution: 2.65 Å Organism(s): Homo Sapiens Sequences Data: 5UVC_A
5VP0
Discovery of clinical candidate n-{(1s)-1-[3-fluoro-4-(trifluoromethoxy)phenyl]-2-methoxyethyl}-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1h)-carboxamide (tak-915), a highly potent, selective, and brain-penetrating phosphodiesterase 2a inhibitor for the treatment of cognitive disorders Deposition Author(s): Hoffman, I.D.
Date: 2017-05-03 Method: X-RAY DIFFRACTION Resolution: 2.2 Å Organism(s): Homo Sapiens Sequences Data: 5VP0_A , 5VP0_B , 5VP0_C
5VP1
Discovery of clinical candidate n-{(1s)-1-[3-fluoro-4-(trifluoromethoxy)phenyl]-2-methoxyethyl}-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1h)-carboxamide (tak-915), a highly potent, selective, and brain-penetrating phosphodiesterase 2a inhibitor for the treatment of cognitive disorders Deposition Author(s): Hoffman, I.D.
Date: 2017-05-03 Method: X-RAY DIFFRACTION Resolution: 1.86 Å Organism(s): Homo Sapiens Sequences Data: 5VP1_A , 5VP1_B , 5VP1_C
6N3L
Identification of novel, potent and selective gcn2 inhibitors as first-in-class anti-tumor agents Deposition Author(s): Cary, D.R. , Ding, S.C. , Fujimoto, J. , Hoffman, I.D. , Kefala, G. , Klein, M.G. , Kurasawa, O. , Mizojiri, R. , Takagi, T.
Date: 2018-11-15 Method: X-RAY DIFFRACTION Resolution: 2.61 Å Organism(s): Homo Sapiens Sequences Data: 6N3L_A , 6N3L_B
6N3N
Identification of novel, potent and selective gcn2 inhibitors as first-in-class anti-tumor agents Deposition Author(s): Cary, D.R. , Ding, S.C. , Fujimoto, J. , Hoffman, I.D. , Kefala, G. , Klein, M.G. , Kurasawa, O. , Mizojiri, R. , Takagi, T.
Date: 2018-11-15 Method: X-RAY DIFFRACTION Resolution: 3.01 Å Organism(s): Homo Sapiens Sequences Data: 6N3N_A
6N3O
Identification of novel, potent and selective gcn2 inhibitors as first-in-class anti-tumor agents Deposition Author(s): Cary, D.R. , Ding, S.C. , Fujimoto, J. , Hoffman, I.D. , Kefala, G. , Klein, M.G. , Kurasawa, O. , Mizojiri, R. , Takagi, T.
Date: 2018-11-15 Method: X-RAY DIFFRACTION Resolution: 2.4 Å Organism(s): Homo Sapiens Sequences Data: 6N3O_A
6OVA
Crystal structure of tyk2 with novel pyrrolidinone inhibitor Deposition Author(s): Hoffman, I.D. , Skene, R.J.
Date: 2019-05-07 Method: X-RAY DIFFRACTION Resolution: 2.5 Å Organism(s): Homo Sapiens Sequences Data: 6OVA_A
6P5M
Discovery of a novel, highly potent, and selective thieno[3,2-d]pyrimidinone-based cdc7 inhibitor with a quinuclidine moiety (tak-931) as an orally active investigational anti-tumor agent Deposition Author(s): Hoffman, I.D. , Skene, R.J.
Date: 2019-05-30 Method: X-RAY DIFFRACTION Resolution: 2.65 Å Organism(s): Homo Sapiens Sequences Data: 6P5M_A , 6P5M_B , 6P5M_C , 6P5M_D
6P5P
Discovery of a novel, highly potent, and selective thieno[3,2-d]pyrimidinone-based cdc7 inhibitor with a quinuclidine moiety (tak-931) as an orally active investigational anti-tumor agent Deposition Author(s): Hoffman, I.D. , Skene, R.J.
Date: 2019-05-30 Method: X-RAY DIFFRACTION Resolution: 3.3 Å Organism(s): Homo Sapiens Sequences Data: 6P5P_A , 6P5P_B , 6P5P_C , 6P5P_D
6UBW
Met tyrosine kinase inhibition enhances the antitumor efficacy of an hgf antibody Deposition Author(s): Hoffman, I.D. , Lawson, J.D.
Date: 2019-09-13 Method: X-RAY DIFFRACTION Resolution: 2 Å Organism(s): Homo Sapiens Sequences Data: 6UBW_A